Artesunate: A Review of its Pharmacology and Therapeutic Efficacy in the Treatment of Malaria

Drugs

Volumn 50, Issue 4, 1995, Pages 714-741

  Barradell, Lee B ^a   Fitton, Andrew ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTEMETHER; ARTEMISININ; ARTESUNATE; DOXYCYCLINE; MEFLOQUINE; MICONAZOLE; PARACETAMOL; PYRIMETHAMINE; QUININE; QUININE SULFATE; SULFADOXINE; TETRACYCLINE;

BLOOD TRANSFUSION; BRADYCARDIA; BRAIN MALARIA; CONVULSION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG RESISTANCE; FEVER; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; MORTALITY; NEUROLOGIC DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PRURITUS; RASH; RECTAL DRUG ADMINISTRATION; RETICULOCYTE; REVIEW; SINUS ARRHYTHMIA; TREATMENT OUTCOME; VERTIGO; VOMITING;

ANTIMALARIALS; CLINICAL TRIALS; COMPARATIVE STUDY; HUMAN; MALARIA, FALCIPARUM; SESQUITERPENES;

EID: 0029090654     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199550040-00009     Document Type: Article

References (101)

1. Qinghaosu (artemisinin): an antimalarial drug from China
2. Antimalarial drug resistance: the pace quickens
3. Antimalarial agents: are we running out of options
4. Indicators of life-threatening malaria in African children
5. Malaria: overview and update
6. Diagnosis, treatment, and prevention of malaria
7. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy
8. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988: II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance
9. Mefloquine resistance in Plasmodium falciparum
10. Arteether, a new antimalarial drug: synthesis and antimalarial properties
11. In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives
12. Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes
13. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum
14. In vitro gametocytocidal activity of artemisinin and its derivatives on Plasmodium falciparum
15. Antimalarial activity of new water-soluble dihydroartemisinin derivatives
16. A nonhuman primate model for human cerebral malaria: effects of artesunate (qinghaosu derivative) on rhesus monkeys experimentally infected with Plasmodium coatneyi
17. The infectivity of gametocytes of plasmodium falciparum from patients treated with artemisinin
18. Effect of sodium artesunate on malaria infected human erythrocytes
19. Peroxidative antimalaria mechanism of sodium artesunate [in Chinese]
20. Activated oxygen mediates the antimalarial activity of qinghaosu
21. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress
22. Antimalarial agents. III. Mechanism of action of artesunate against Plasmodium berghei infection
23. Antimalarial agents, 2. Artesunate, an inhibitor of cytochrome oxidase activity in Plasmodium berghei
24. Treatment of malaria — 1990
25. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
26. Drug sensitivity of Plasmodium falciparum: an in-vitro microtechnique
27. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method
28. Effects of artesunate, pyronaridine and hydroxypiperaquine on chloroquine-sensitive and chloroquine-resistant isolates of Plasmodium falciparum in vitro [in Chinese]
29. Sensitivity in vitro of Plasmodium falciparum to chloroquine, pyronaridine, artesunate and piperaquine in south Yunnan [in Chinese]
30. In vitro development of sodium artesunate resistance in Plasmodium falciparum [in Chinese]
31. Qinghaosu resistance in rodent malaria
32. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
33. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria
34. Treatment of acute uncomplicated Falciparum malaria with a short course of artesunate followed by mefloquine
35. Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine
36. Antimalarial pharmacokinetics and treatment regimens
37. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
38. Determination of artesunate and dihydroartemisinine in plasma by liquid chro-matography with post-column derivatization and UV-detection
39. Pharmacokinetics of sodium artesunate after IM and IV administration [abstract no. 415]
40. Comparison of pharmacokinetics, bioavailability and hydrolysis of dihydroartemisinin, arteether, artesunate and artelinate in rats [abstract no. 298]
41. Analysis of artesunic acid and dihydroqinghaosu in blood by high-performance liquid chromatography with reductive electrochemical detection
42. Metabolism of antimalarial sesquiterpene lactones
43. 3]dihydroartemisinine by erythrocytes infected with Plasmodium falciparum in vitro
44. Effects of qinghaosu on the surface structure of erythrocytes infected with Plasmodium berghei and the erythrocyte-free parasites
45. A preliminary study on the urinary excretion of artesunate and its metabolites in man after a single intravenous injection [in Chinese]
46. Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs
47. Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs
48. Malaria
49. Severe and complicated malaria
50. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination
51. A study to determine the dose of intravenous injections of artesunate in the treatment of falciparum malaria: clinical phase II
52. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand: a preliminary report
53. Double blind randomised clinical trial of two different regimens of oral artesunate in falciparum malaria
54. Double blind randomised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria
55. Thirty three patients with cerebral malaria treated with intravenous artesunate
56. Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives
57. A randomised comparative study of artesunate versus quinine dihydrochloride in the treatment of falciparum malaria
58. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria
59. A summary of the clinical studies on artesunate intravenous injection in malaria patients
60. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China
61. Clinical studies on the treatment of malaria with qinghaosu and its derivatives
62. Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria
63. Pharmacokinetics of mefloquine alone or in combination with artesunate
64. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria
65. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria
66. Clinical studies on the treatment of falciparum malaria with artesunate intramuscular injection and a randomly controlled study on artesunate and piperaquine
67. A randomised comparative study on the treatment of falciparum malaria with artesunate tablets and piperaquine
68. Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border
69. Single day mefloquine-artesunate combination in the treatment of multidrug resistant faciparum malaria
70. Artemisinin compounds in treatment of malaria [letter; comment]
71. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro
72. The effect of combinations of qinghaosu (artemisinin) with standard anti-malarial drugs in the suppressive treatment of malaria in mice
73. Drug resistant malaria, with special reference to Thailand
74. Clinical malaria in the tropics
75. A new look at an old drug: artemesinin and qinghaosu
76. An open randomized comparison of intravenous and intramuscular artesunate in severe falciparum malaria
77. New antimalarials: a risk-benefit analysis
78. Neurotoxicity of artemisinin analogs in vitro
79. A study on tolerance and toxic side-effects of artesunate intravenous injection on healthy volunteers: clinical trials phase I
80. Overview of clinical studies on artemisinin derivatives in Thailand
81. Artemisinin: large community studies
82. Qinghaosu
83. Follow up observations on pregnant women with malaria treated with qinghaosu and its derivatives
84. Studies on the toxicity of qinghaosu and its derivatives
85. Artemisinin: current status
86. Chemical stability of artesunic acid injection, a new antimalarial drug derived from qinghaosu [abstract no. 2]
87. Medical considerations for the pregnant traveler
88. Malaria in Viet-nam: environment, prevention and treatment [in French]
89. Malaria: living with drug resistance
90. Single dose artemisininmefloquine treatment for acute uncomplicated falciparum malaria